Kisspeptin: a critical regulator of puberty and reproductive function.
Sam. Amir H AH; Dhillo. Waljit S WS
Key Findings
- Kisspeptin is essential for initiating puberty and regulating the reproductive hormone axis.
- Loss‑of‑function mutations in its receptor cause hypogonadotropic hypogonadism, while gain‑of‑function mutations lead to precocious puberty.
- Kisspeptin stimulates gonadotropin release mainly by activating GnRH release, making it a potential therapeutic target.
Practical Outcomes
- For now, the main takeaway is that kisspeptin could become a future tool for managing hormone‑related conditions, but biohackers don’t have actionable dosing or protocols to apply today. Keep an eye on emerging therapies that might use kisspeptin analogs for fertility or hormone balance.
Summary
Kisspein-10 is a protein that helps start puberty and control reproductive hormones by telling the brain to release GnRH, which then triggers gonadotropins. Mutations that stop its receptor cause low hormone levels, while activating mutations can cause early puberty. Scientists see it as a possible drug target for tweaking the reproductive hormone system, but there are no ready‑to‑use dosing guidelines yet.
Abstract
Kisspeptin has emerged as a critical player in the initiation of puberty and reproductive function. In humans, inactivating mutations of the kisspeptin receptor result in hypogonadotrophic hypogonadism and kisspeptin receptor activating mutations cause precocious puberty. Kisspeptin potently stimulates the release of gonadotrophins predominantly through the release of gonadotrophin-releasing hormone (GnRH). Here we review the data from animal and human studies exploring the role of kisspeptin in the regulation of the hypothalamic-pituitary-gonadal (HPG) axis. Kisspeptin signalling presents a novel target for therapeutic manipulation of the HPG axis.
Study Information
pubmed
2010
2010-07-31T00:00:00.000Z
10.2174/138945010791591359
7